Analysis of serum cytokine levels in primary biliary cirrhosis patients and healthy adults

Journal of Clinical Laboratory Analysis

Volumn 12, Issue 2, 1998, Pages 77-82

  Yamashiki, Masayoshi ^a   Kosaka, Yoshitane ^a   Nishimura, Akira ^b   Watanabe, Shozo ^a   Nomoto, Minoru ^c   Ichida, Fumihiro ^c  

^a MIE UNIVERSITY   (Japan)

^b SUZUKA GENERAL HOSPITAL   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

Author keywords

Chronic liver diseases; Cytokine; IL 6; Primary biliary cirrhosis; Serum cytokine level; TNF

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BILIARY CIRRHOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

ADULT; AGED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-6; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; REFERENCE VALUES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031940205     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2825(1998)12:2<77::AID-JCLA1>3.0.CO;2-G     Document Type: Article

References (19)

1. Tigl H, Wilmer A, Vogel W, et al.: Serum levels of cytokines in chronic liver diseases. Gastroenterology 103:264-274, 1992.
2. Sun Y, Tokushige K, Isono E, Yamauchi K, Obata H: Elevated serum interleukin-6 levels in patients with acute hepatitis. J Clin Immunol 12:197-200, 1992.
3. Hill DB, Marsano LS, McClain CJ: Increased plasma interleukin-8 concentrations in alcoholic hepatitis. Hepatology 18:576-580, 1993.
4. Muto Y, Noun-Aria KT, Meager A, Alexander GJM, Eddleston ALWF, Williams R: Enhanced tumor necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 2:72-74, 1988.
5. Yamashiki M, Kosaka Y, Nishimura A, Takase K, Ichida F: Efficacy of a herbal medicine "Sho-saiko-to" on the improvement of impaired cytokine production of peripheral blood mononuclear cells in patients with chronic viral hepatitis. J Clin Lab Immunol 37:111-121, 1992.
6. Al-Wabel A, Al-Janadi M, Raziuddin S: Cytokine profile of viral and autoimmune chronic active hepatitis. J Allergy Clin Immunol 92:902-908, 1993.
7. Yamashiki M, Nishimura A: Dysregulation of cytokine network in primary biliary cirrhosis. Gastroenterol Jpn 28:607, 1993.
8. Yamashiki M, Nishimura A, Nomoto M, Suzuki H, Kosaka Y: Herbal medicine "Sho-saiko-to" induces tumor necrosis factor-α and granulocyte colony-stimulating factor in vitro in peripheral blood mononuclear cells of patients with hepatocellular carcinoma. J Gastroenterol Hepatol 11:137-142, 1996.
9. Schlaak JF, Löhr H, Gallati H, Meyer zum Büschenfelde K-H, Fleischer B: Analysis of the in vitro cytokine production by liver-infiltrating T cells of patients with autoimmune hepatitis. Clin Exp Immunol 94:168-173, 1993.
10. Martinez OM, Villanueva JC, Gershwin ME, Krams SM: Cytokine patterns and cytokine mediators in primary biliary cirrhosis. Hepatology 21:113-119, 1995.
11. Ida N, Sakurai S, Hosaka T, et al.: An enzyme-linked immunosorbent assay for the measurement of human interleukin-6. J Immunol Methods 133:279-284, 1990.
12. Yamashiki M, Nishimura A, Kosaka Y, James SP: Two-color analysis of peripheral lymphocytes surface antigens in inherently healthy adults. J Clin Lab Anal 8:22-26, 1994.
13. Roll J, Boyer JL, Barry D, Klatskin G: The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. New Engl J Med 308:1-7, 1983.
14. Stoline MR: The status of multiple comparisons: simultaneous estimation of all pairwise comparisons in one-way ANOVA designs. Am Stat 35:134-141, 1981.
15. Skoskiewicz MJ, Colvin RB, Schneeberger EE, Russell PS: Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon. J Exp Med 162:1645-1664, 1985.
16. Steiniger B, Falk P, Lohmuller M, vad der Meide PH: Class II MHC antigens in the rat digestive system: normal distribution and induced expression after interferon gamma treatment in vivo. Immunology 68:507-513, 1989.
17. Yamashiki M: Peripheral blood lymphocyte subsets in primary biliary cirrhosis. Acta Hepatologica Japonica 20:1684-1691, 1986.
18. Yamashiki M, Honda K, Ohta H, Arakawa K, Ichida F: Immunoregulatory disorders in primary biliary cirrhosis. Medical Immunology 12:643-647, 1986.
19. Yamashiki M, Suzuki K, Deyashiki Y, et al.: Abnormal prothrombin (PIVKA-II) as a marker of hepatocellular carcinoma. Mie Med J 39:33-38, 1989.